Search

everythinglearnresearchcommunity

for

Search:↓

Resveratrol-loaded nanoparticles show promise for lung cancer treatment.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

Scalp cooling therapy is costly and often not covered by insurance, limiting access for low-income patients.

The protein p53 directly reduces the production of Keratin 17, a skin and hair protein, in rats with radiation dermatitis.

Using polymeric micelles to deliver spironolactone topically could improve wound healing in skin affected by glucocorticoids.

Mice with extra PKCδ resist chemical-induced skin cancer but not UV-induced.

Boosting certain cell signals can prevent hair loss from cancer treatments.

PPX causes much less hair loss than traditional taxanes.

17-beta estradiol and prednisolone may help regrow hair damaged by chemotherapy.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

CI-1033 causes skin lesions in rats, similar to humans, due to EGF receptor inhibition.

Raltitrexed conjugates are less potent than the free drug but more effective at high concentrations.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

Ethanol and methanol extracts of Spirulina platensis do not kill WiDr colon cancer cells.

Topical minoxidil and dietary supplements improved hair regrowth in children with hair loss from chemotherapy.

Anlotinib combined with taxane/capecitabine is more effective than bevacizumab for treating HER-2 negative metastatic breast cancer.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Glibenclamide slows breast cancer cell growth by stopping cell division.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

CoCr2O4 catalysts effectively and sustainably produce diaminopyrimidine oxides with high yield.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

Researchers made new compounds that could potentially be developed into anticancer drugs.

Radiation therapy with a higher dose for the brain improves survival in cerebellar medulloblastoma.

Surgical excision is the best treatment for SCC, but intralesional cidofovir might be a good alternative.

Irradiating the whole central nervous system can lead to over 50% of patients with cerebellar medulloblastoma surviving three years.